Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 12 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 543318 | NSE: CLEAN

Clean Science & Technology Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 10:13 am

Market Cap 13,507 Cr.
Current Price 1,271
High / Low 1,690/1,106
Stock P/E51.8
Book Value 122
Dividend Yield0.39 %
ROCE29.6 %
ROE22.0 %
Face Value 1.00
PEG Ratio9.26

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Clean Science & Technology Ltd

Competitors of Clean Science & Technology Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
HP Adhesives Ltd 431 Cr. 47.0 115/42.622.3 19.20.64 %17.7 %12.6 % 2.00
Haryana Leather Chemicals Ltd 38.3 Cr. 78.0 124/56.89.30 87.21.28 %8.96 %7.25 % 10.0
Hardcastle & Waud Mfg Co Ltd 48.3 Cr. 710 1,355/56327.6 6630.00 %7.00 %5.98 % 10.0
Grauer & Weil (India) Ltd 4,145 Cr. 91.4 120/72.225.8 19.20.55 %26.1 %19.6 % 1.00
DMCC Speciality Chemicals Ltd 765 Cr. 298 453/24536.7 85.40.34 %7.55 %2.89 % 10.0
Industry Average9,517.86N/A40.12N/AN/A13.9910.39N/A

All Competitor Stocks of Clean Science & Technology Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 181205234248237217188181195228224238241
Expenses 105121143150129112112106108133129148142
Operating Profit 7684919710810576758795959098
OPM % 42%41%39%39%46%48%40%41%44%42%42%38%41%
Other Income 7723131313681410115
Interest 0000000001000
Depreciation 678991011111113161818
Profit before tax 7884859211210879698395898385
Tax % 25%26%26%26%25%25%25%25%25%26%26%29%23%
Net Profit 58626368848159526370665966
EPS in Rs 5.465.875.926.407.897.585.554.915.896.616.205.536.18

Last Updated: February 28, 2025, 4:44 pm

Below is a detailed analysis of the quarterly data for Clean Science & Technology Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹241.00 Cr.. The value appears strong and on an upward trend. It has increased from 238.00 Cr. (Sep 2024) to ₹241.00 Cr., marking an increase of ₹3.00 Cr..
  • For Expenses, as of Dec 2024, the value is ₹142.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 148.00 Cr. (Sep 2024) to ₹142.00 Cr., marking a decrease of 6.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹98.00 Cr.. The value appears strong and on an upward trend. It has increased from 90.00 Cr. (Sep 2024) to ₹98.00 Cr., marking an increase of ₹8.00 Cr..
  • For OPM %, as of Dec 2024, the value is 41.00%. The value appears strong and on an upward trend. It has increased from 38.00% (Sep 2024) to 41.00%, marking an increase of 3.00%.
  • For Other Income, as of Dec 2024, the value is ₹5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Sep 2024) to ₹5.00 Cr., marking a decrease of 6.00 Cr..
  • For Interest, as of Dec 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹18.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 18.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹85.00 Cr.. The value appears strong and on an upward trend. It has increased from 83.00 Cr. (Sep 2024) to ₹85.00 Cr., marking an increase of ₹2.00 Cr..
  • For Tax %, as of Dec 2024, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Sep 2024) to 23.00%, marking a decrease of 6.00%.
  • For Net Profit, as of Dec 2024, the value is ₹66.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Sep 2024) to ₹66.00 Cr., marking an increase of ₹7.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 6.18. The value appears strong and on an upward trend. It has increased from ₹5.53 (Sep 2024) to 6.18, marking an increase of ₹0.65.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 2:39 pm

MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 241393419512685936791930
Expenses 167257234253385533459553
Operating Profit 74137186260300403332377
OPM % 31%35%44%51%44%43%42%41%
Other Income 511112530304140
Interest 10000111
Depreciation 811141725364664
Profit before tax 70137182267305396326352
Tax % 30%28%23%26%25%25%25%
Net Profit 4998140198228295244261
EPS in Rs 345.41689.841,051.6718.6821.5127.7822.9724.52
Dividend Payout % 12%15%2%134%15%18%22%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)100.00%42.86%41.43%15.15%29.39%-17.29%
Change in YoY Net Profit Growth (%)0.00%-57.14%-1.43%-26.28%14.23%-46.67%

Clean Science & Technology Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2018-2019 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:%
5 Years:15%
3 Years:16%
TTM:19%
Compounded Profit Growth
10 Years:%
5 Years:20%
3 Years:7%
TTM:2%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:-16%
1 Year:-9%
Return on Equity
10 Years:%
5 Years:33%
3 Years:29%
Last Year:22%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 7:31 pm

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 1111111111111
Reserves 1862713415297589991,1931,287
Borrowings 13300222
Other Liabilities 485385120156140191201
Total Liabilities 2363274306609251,1521,3961,501
Fixed Assets 102127166186296460636687
CWIP 2435544205730
Investments 1875133232191353339359
Other Assets 114121128187394318363425
Total Assets 2363274306609251,1521,3961,501

Below is a detailed analysis of the balance sheet data for Clean Science & Technology Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹11.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹1,287.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,193.00 Cr. (Mar 2024) to ₹1,287.00 Cr., marking an increase of 94.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹2.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded ₹2.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹201.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹191.00 Cr. (Mar 2024) to ₹201.00 Cr., marking an increase of 10.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹1,501.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹1,396.00 Cr. (Mar 2024) to ₹1,501.00 Cr., marking an increase of 105.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹687.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹636.00 Cr. (Mar 2024) to ₹687.00 Cr., marking an increase of 51.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹30.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹57.00 Cr. (Mar 2024) to ₹30.00 Cr., marking a decrease of 27.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹359.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹339.00 Cr. (Mar 2024) to ₹359.00 Cr., marking an increase of 20.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹425.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹363.00 Cr. (Mar 2024) to ₹425.00 Cr., marking an increase of 62.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹1,501.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,396.00 Cr. (Mar 2024) to ₹1,501.00 Cr., marking an increase of 105.00 Cr..

Notably, the Reserves (₹1,287.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +4585160193127279237
Cash from Investing Activity +-17-94-105-187-79-270-186
Cash from Financing Activity +-5-11-55-6-0-55-53
Net Cash Flow23-20-0049-45-2

Free Cash Flow

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow73.00134.00183.00260.00300.00401.00330.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days60556153825776
Inventory Days937998156143122163
Days Payable854810118016690143
Cash Conversion Cycle69875829598996
Working Capital Days60643532906886
ROCE %59%59%61%47%44%30%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters78.51%78.51%78.50%78.50%78.50%74.98%74.98%74.98%74.98%74.98%74.97%74.97%
FIIs5.18%4.43%4.43%3.99%3.99%5.84%6.01%5.92%5.88%6.05%5.83%5.98%
DIIs4.02%4.51%4.48%4.65%4.76%6.41%5.23%5.13%5.04%4.55%4.77%5.46%
Public12.29%12.55%12.58%12.86%12.74%12.78%13.79%13.98%14.11%14.42%14.43%13.59%
No. of Shareholders2,63,5932,70,4462,70,6162,75,1022,70,8232,66,9712,85,2592,78,6532,79,3952,73,8412,54,6292,46,798

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Axis ELSS Tax Saver Fund878,4700.33116.78282,0152025-03-11211.5%
Axis Growth Opportunities Fund433,0220.4957.56282,0152025-03-1153.55%
Axis Flexi Cap Fund420,6730.4855.92282,0152025-03-1149.17%
PGIM India Midcap Opportunities Fund365,7120.4948.62282,0152025-03-1129.68%
Aditya Birla Sun Life Small Cap Fund358,8381.0747.7282,0152025-03-1127.24%
Aditya Birla Sun Life Equity Hybrid 95 Fund312,2090.5641.5282,0152025-03-1110.71%
Aditya Birla Sun Life Equity Advantage Fund285,7140.6937.98282,0152025-03-111.31%
Invesco India ELSS Tax Saver Fund282,0151.4837.49282,0152025-03-110%
Nippon India Retirement Fund - Wealth Creation Scheme170,0000.7522.6282,0152025-03-11-39.72%
Axis Multi Asset Allocation Fund97,3151.112.94282,0152025-03-11-65.49%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 1.001.001.001.0010.00
Basic EPS (Rs.) 22.9727.7921.5118.6813.15
Diluted EPS (Rs.) 22.9627.7821.5118.6813.15
Cash EPS (Rs.) 27.2931.1823.8620.301154.71
Book Value[Excl.RevalReserv]/Share (Rs.) 113.2495.0772.3450.812576.03
Book Value[Incl.RevalReserv]/Share (Rs.) 113.2495.0772.3450.812576.03
Revenue From Operations / Share (Rs.) 74.4988.0864.4848.243157.38
PBDIT / Share (Rs.) 35.1440.6631.0526.791477.04
PBIT / Share (Rs.) 30.8237.2628.7125.171373.77
PBT / Share (Rs.) 30.7337.2428.6925.161372.86
Net Profit / Share (Rs.) 22.9727.7821.5118.681051.44
NP After MI And SOA / Share (Rs.) 22.9727.7821.5118.681051.44
PBDIT Margin (%) 47.1746.1548.1655.5346.78
PBIT Margin (%) 41.3642.2944.5252.1843.50
PBT Margin (%) 41.2542.2744.5052.1643.48
Net Profit Margin (%) 30.8331.5433.3638.7133.30
NP After MI And SOA Margin (%) 30.8331.5433.3638.7133.30
Return on Networth / Equity (%) 20.2829.2229.7336.7540.81
Return on Capital Employeed (%) 26.4838.1938.6147.9251.69
Return On Assets (%) 17.4725.6224.7130.0632.48
Total Debt / Equity (X) 0.000.000.000.000.01
Asset Turnover Ratio (%) 0.620.890.860.941.11
Current Ratio (X) 4.125.464.233.873.34
Quick Ratio (X) 3.354.513.573.362.89
Inventory Turnover Ratio (X) 2.433.443.483.153.57
Dividend Payout Ratio (NP) (%) 21.7618.890.000.002.53
Dividend Payout Ratio (CP) (%) 18.3216.830.000.002.30
Earning Retention Ratio (%) 78.2481.110.000.0097.47
Cash Earning Retention Ratio (%) 81.6883.170.000.0097.70
Interest Coverage Ratio (X) 403.192214.972243.953127.441621.08
Interest Coverage Ratio (Post Tax) (X) 264.531514.721555.392181.001154.98
Enterprise Value (Cr.) 14100.4313420.0321095.820.000.00
EV / Net Operating Revenue (X) 17.8214.3430.800.000.00
EV / EBITDA (X) 37.7731.0763.950.000.00
MarketCap / Net Operating Revenue (X) 17.8314.3530.910.000.00
Retention Ratios (%) 78.2381.100.000.0097.46
Price / BV (X) 11.7313.3027.550.000.00
Price / Net Operating Revenue (X) 17.8314.3530.910.000.00
EarningsYield 0.010.020.010.000.00

After reviewing the key financial ratios for Clean Science & Technology Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 22.97. This value is within the healthy range. It has decreased from 27.79 (Mar 23) to 22.97, marking a decrease of 4.82.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 22.96. This value is within the healthy range. It has decreased from 27.78 (Mar 23) to 22.96, marking a decrease of 4.82.
  • For Cash EPS (Rs.), as of Mar 24, the value is 27.29. This value is within the healthy range. It has decreased from 31.18 (Mar 23) to 27.29, marking a decrease of 3.89.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 113.24. It has increased from 95.07 (Mar 23) to 113.24, marking an increase of 18.17.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 113.24. It has increased from 95.07 (Mar 23) to 113.24, marking an increase of 18.17.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 74.49. It has decreased from 88.08 (Mar 23) to 74.49, marking a decrease of 13.59.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 35.14. This value is within the healthy range. It has decreased from 40.66 (Mar 23) to 35.14, marking a decrease of 5.52.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 30.82. This value is within the healthy range. It has decreased from 37.26 (Mar 23) to 30.82, marking a decrease of 6.44.
  • For PBT / Share (Rs.), as of Mar 24, the value is 30.73. This value is within the healthy range. It has decreased from 37.24 (Mar 23) to 30.73, marking a decrease of 6.51.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 22.97. This value is within the healthy range. It has decreased from 27.78 (Mar 23) to 22.97, marking a decrease of 4.81.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 22.97. This value is within the healthy range. It has decreased from 27.78 (Mar 23) to 22.97, marking a decrease of 4.81.
  • For PBDIT Margin (%), as of Mar 24, the value is 47.17. This value is within the healthy range. It has increased from 46.15 (Mar 23) to 47.17, marking an increase of 1.02.
  • For PBIT Margin (%), as of Mar 24, the value is 41.36. This value exceeds the healthy maximum of 20. It has decreased from 42.29 (Mar 23) to 41.36, marking a decrease of 0.93.
  • For PBT Margin (%), as of Mar 24, the value is 41.25. This value is within the healthy range. It has decreased from 42.27 (Mar 23) to 41.25, marking a decrease of 1.02.
  • For Net Profit Margin (%), as of Mar 24, the value is 30.83. This value exceeds the healthy maximum of 10. It has decreased from 31.54 (Mar 23) to 30.83, marking a decrease of 0.71.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 30.83. This value exceeds the healthy maximum of 20. It has decreased from 31.54 (Mar 23) to 30.83, marking a decrease of 0.71.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 20.28. This value is within the healthy range. It has decreased from 29.22 (Mar 23) to 20.28, marking a decrease of 8.94.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 26.48. This value is within the healthy range. It has decreased from 38.19 (Mar 23) to 26.48, marking a decrease of 11.71.
  • For Return On Assets (%), as of Mar 24, the value is 17.47. This value is within the healthy range. It has decreased from 25.62 (Mar 23) to 17.47, marking a decrease of 8.15.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.00.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.62. It has decreased from 0.89 (Mar 23) to 0.62, marking a decrease of 0.27.
  • For Current Ratio (X), as of Mar 24, the value is 4.12. This value exceeds the healthy maximum of 3. It has decreased from 5.46 (Mar 23) to 4.12, marking a decrease of 1.34.
  • For Quick Ratio (X), as of Mar 24, the value is 3.35. This value exceeds the healthy maximum of 2. It has decreased from 4.51 (Mar 23) to 3.35, marking a decrease of 1.16.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.43. This value is below the healthy minimum of 4. It has decreased from 3.44 (Mar 23) to 2.43, marking a decrease of 1.01.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 21.76. This value is within the healthy range. It has increased from 18.89 (Mar 23) to 21.76, marking an increase of 2.87.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 18.32. This value is below the healthy minimum of 20. It has increased from 16.83 (Mar 23) to 18.32, marking an increase of 1.49.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 78.24. This value exceeds the healthy maximum of 70. It has decreased from 81.11 (Mar 23) to 78.24, marking a decrease of 2.87.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 81.68. This value exceeds the healthy maximum of 70. It has decreased from 83.17 (Mar 23) to 81.68, marking a decrease of 1.49.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 403.19. This value is within the healthy range. It has decreased from 2,214.97 (Mar 23) to 403.19, marking a decrease of 1,811.78.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 264.53. This value is within the healthy range. It has decreased from 1,514.72 (Mar 23) to 264.53, marking a decrease of 1,250.19.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 14,100.43. It has increased from 13,420.03 (Mar 23) to 14,100.43, marking an increase of 680.40.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 17.82. This value exceeds the healthy maximum of 3. It has increased from 14.34 (Mar 23) to 17.82, marking an increase of 3.48.
  • For EV / EBITDA (X), as of Mar 24, the value is 37.77. This value exceeds the healthy maximum of 15. It has increased from 31.07 (Mar 23) to 37.77, marking an increase of 6.70.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 17.83. This value exceeds the healthy maximum of 3. It has increased from 14.35 (Mar 23) to 17.83, marking an increase of 3.48.
  • For Retention Ratios (%), as of Mar 24, the value is 78.23. This value exceeds the healthy maximum of 70. It has decreased from 81.10 (Mar 23) to 78.23, marking a decrease of 2.87.
  • For Price / BV (X), as of Mar 24, the value is 11.73. This value exceeds the healthy maximum of 3. It has decreased from 13.30 (Mar 23) to 11.73, marking a decrease of 1.57.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 17.83. This value exceeds the healthy maximum of 3. It has increased from 14.35 (Mar 23) to 17.83, marking an increase of 3.48.
  • For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 23) to 0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Clean Science & Technology Ltd as of March 12, 2025 is: ₹1,116.59

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Clean Science & Technology Ltd is Overvalued by 12.15% compared to the current share price 1,271.00

Intrinsic Value of Clean Science & Technology Ltd as of March 12, 2025 is: 1,179.02

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Clean Science & Technology Ltd is Overvalued by 7.24% compared to the current share price 1,271.00

Last 5 Year EPS CAGR: 5.59%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 42.86%, which is a positive sign.
  2. The company has higher reserves (695.50 cr) compared to borrowings (1.63 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (613.38 cr) and profit (254.38 cr) over the years.
  1. The stock has a high average Working Capital Days of 62.14, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 69.57, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Clean Science & Technology Ltd:
    1. Net Profit Margin: 30.83%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 26.48% (Industry Average ROCE: 13.99%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 20.28% (Industry Average ROE: 10.39%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 264.53
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 3.35
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 51.8 (Industry average Stock P/E: 40.12)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Clean Science & Technology Ltd. is a Public Limited Listed company incorporated on 07/11/2003 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24114PN2003PLC018532 and registration number is 018532. Currently Company is involved in the business activities of Manufacture of various other chemical products(antiknock preparations, anti-freeze preparations, liquids for hydraulic transmission, composite diagnostic or laboratory reagents, writing or drawing ink, chemical substance used in manufacturing of pesticides and other chemical products). Company's Total Operating Revenue is Rs. 789.44 Cr. and Equity Capital is Rs. 10.63 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Chemicals - Speciality - OthersOffice No. 503, Pentagon Tower P-4, Pune Maharashtra 411013compliance@cleanscience.co.in
http://www.cleanscience.co.in
Management
NamePosition Held
Mr. Pradeep RathiChairman & Non-Exe.Director
Mr. Ashok BoobManaging Director
Mr. Siddhartha SikchiExecutive Director
Mr. Krishnakumar BoobExecutive Director
Mr. Sanjay KothariNon Executive Director
Prof. Ganapati YadavInd. Non-Executive Director
Mr. Keval DoshiInd. Non-Executive Director
Ms. Madhu DubhashiInd. Non-Executive Director
Mr. Parth MaheshwariAdditional Executive Director

FAQ

What is the latest intrinsic value of Clean Science & Technology Ltd?

The latest intrinsic value of Clean Science & Technology Ltd as on 09 March 2025 is ₹1116.59, which is 12.15% lower than the current market price of 1,271.00, indicating the stock is overvalued by 12.15%. The intrinsic value of Clean Science & Technology Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹13,507 Cr. and recorded a high/low of ₹1,690/1,106 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹1,287 Cr and total liabilities of ₹1,501 Cr.

What is the Market Cap of Clean Science & Technology Ltd?

The Market Cap of Clean Science & Technology Ltd is 13,507 Cr..

What is the current Stock Price of Clean Science & Technology Ltd as on 09 March 2025?

The current stock price of Clean Science & Technology Ltd as on 09 March 2025 is ₹1,271.

What is the High / Low of Clean Science & Technology Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Clean Science & Technology Ltd stocks is ₹1,690/1,106.

What is the Stock P/E of Clean Science & Technology Ltd?

The Stock P/E of Clean Science & Technology Ltd is 51.8.

What is the Book Value of Clean Science & Technology Ltd?

The Book Value of Clean Science & Technology Ltd is 122.

What is the Dividend Yield of Clean Science & Technology Ltd?

The Dividend Yield of Clean Science & Technology Ltd is 0.39 %.

What is the ROCE of Clean Science & Technology Ltd?

The ROCE of Clean Science & Technology Ltd is 29.6 %.

What is the ROE of Clean Science & Technology Ltd?

The ROE of Clean Science & Technology Ltd is 22.0 %.

What is the Face Value of Clean Science & Technology Ltd?

The Face Value of Clean Science & Technology Ltd is 1.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Clean Science & Technology Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE